Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

322
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Lipid Absorption01:24

Lipid Absorption

2.5K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-orchestrated design-build-test-learn is the future of mammalian biodesign.

Nature biomedical engineering·2026
Same author

Optical UVA biosensor platform for high-throughput testing of UV blockers.

The Journal of investigative dermatology·2026
Same author

Self-driving medicine: closed-loop therapeutics for autonomous disease control.

Trends in biotechnology·2026
Same author

A synthetic angiotensin II/ACE2-based hormone shunt controlling experimental hypertension.

Nature communications·2026
Same author

Next-generation programmable cell therapies for precision medicine.

Nature reviews. Genetics·2026
Same author

Traceless Regulation of Genetic Circuitry.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Related Experiment Video

Updated: Jan 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.0K

A closed-loop cholesterol shunt controlling experimental dyslipidemia.

Gokberk Unal1, Yu-Qing Xie1, Martin Fussenegger2

  • 1Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zurich, Schanzenstrasse 48, 4056 Basel, Switzerland.

Cell Metabolism
|September 19, 2025
PubMed
Summary

A novel genetic circuit, CHARM, effectively senses and regulates high cholesterol levels in real time. This engineered system restored cholesterol homeostasis in hypercholesterolemic mice, offering a new therapeutic strategy for managing dyslipidemia.

Keywords:
LDLPCSK9atherosclerosiscell engineeringcholesteroldesigner cellsgene switchhypercholesterolemiasynthetic biologytherapeutic genetic circuit

More Related Videos

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.6K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.0K

Related Experiment Videos

Last Updated: Jan 17, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.0K
Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

30.6K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.0K

Area of Science:

  • Biotechnology and Genetic Engineering
  • Metabolic Disorders and Cardiovascular Health
  • Synthetic Biology Applications

Background:

  • Hypercholesterolemia, characterized by dysregulated lipid metabolism, is a primary risk factor for atherosclerosis and cardiovascular diseases.
  • Current therapeutic strategies for dyslipidemia face challenges in real-time monitoring and sustained regulation.
  • The need for innovative approaches to restore and maintain cholesterol homeostasis is critical.

Purpose of the Study:

  • To develop a designer genetic circuit, the Cholesterol Homeostasis and Regulation Module (CHARM), for real-time sensing and regulation of cholesterol levels.
  • To engineer a closed-loop system that strengthens the body's innate cholesterol homeostasis machinery.
  • To evaluate the efficacy of CHARM in restoring cholesterol balance in a preclinical model.

Main Methods:

  • Engineered a synthetic genetic circuit (CHARM) utilizing a fusion protein (KRAB-SREBP1a) as a cholesterol sensor.
  • Integrated a synthetic expression module with SRE operator sites to control therapeutic protein production.
  • Implanted microencapsulated CHARM-transgenic human cells into hypercholesterolemic mice.

Main Results:

  • CHARM successfully sensed elevated cholesterol levels in real time.
  • Implantation of CHARM-transgenic cells rapidly restored cholesterol homeostasis in hypercholesterolemic mice.
  • Stable maintenance of cholesterol homeostasis was achieved through the closed-loop regulation of the genetic circuit.

Conclusions:

  • The CHARM genetic circuit represents a promising synthetic biology approach for managing hypercholesterolemia.
  • This engineered system demonstrates the potential for closed-loop, real-time regulation of metabolic disorders.
  • CHARM offers a novel strategy for restoring and maintaining cholesterol balance, potentially reducing cardiovascular disease risk.